Skip to main content

Table 2 Assessment of Liver Biochemistry and Lipids

From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

 

Control

PBC (0th week)

TN

sham-TN

before

after

before

after

AST (U/L, mean ± SD)

23.30 ± 4.57

37.70 ± 12.90^

37.10 ± 14.71

36.50 ± 16.71

34.70 ± 14.97

36.80 ± 19.62

ALT (U/L, mean ± SD)

16.30 ± 6.41

47.30 ± 23.16^

46.40 ± 27.35

38.30 ± 25.17

38.80 ± 24.49

42.70 ± 35.24

ALP (U/L, mean ± SD)

62.00 ± 15.36

204.40 ± 94.51^

191.40 ± 70.42

148.50 ± 49.66*

178.40 ± 99.61

165.30 ± 65.75

γ-GT (U/L, mean ± SD, Median50(M25 ~ M75))

22.20 ± 8.53

287.60 ± 176.38^

217.00 (126.75 ~ 418.50)

138.50 (102.50 ~ 302.25)*

165.00 (111.50 ~ 348.25)

151.50 (91.75 ~ 314.75)

TC (mmol/l, mean ± SD)

4.58 ± 0.53

5.87 ± 1.59^

6.01 ± 1.27

5.94 ± 1.68

5.78 ± 1.83

6.05 ± 1.25

TG (mmol/l, mean ± SD)

1.06 ± 0.50

1.32 ± 0.66

1.43 ± 0.69

1.42 ± 0.37

1.28 ± 0.4

1.28 ± 0.45